# Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

> **NCT07640191** · NA · RECRUITING · sponsor: **iVEAcare** · enrollment: 30 (estimated)

## Conditions studied

- Drug Resistant Epilepsy

## Interventions

- **DEVICE:** iVEAcare Neuromodulation System

## Key facts

- **NCT ID:** NCT07640191
- **Lead sponsor:** iVEAcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-29
- **Primary completion:** 2027-07
- **Final completion:** 2032-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640191, "Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*